Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
HJLI Stock Forecast 2026-2027
$0.34
Current Price
$2.97M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to HJLI Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
HJLI Price Momentum
0.0%
1 Week Change
+6.3%
1 Month Change
-89.7%
1 Year Change
+6.3%
Year-to-Date Change
-93.9%
From 52W High of $5.62
+13.6%
From 52W Low of $0.30
📊 TOP ANALYST CALLS
Did HJLI Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Hancock Jaffe is one of their latest high-conviction picks.
Latest HJLI Stock Price Targets & Analyst Predictions
HJLI has shown a year-to-date change of 6.3% and a 1-year change of -89.7%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for HJLI. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HJLI Analyst Ratings
0
Buy
0
Hold
0
Sell
HJLI Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.34
Latest HJLI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HJLI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Hancock Jaffe Laboratories Inc (HJLI) Competitors
The following stocks are similar to Hancock Jaffe based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
HJLI
Hancock Jaffe
mkt cap
2.97M
Hancock Jaffe Laboratories Inc (HJLI) Financial Data
Valuation Metrics
Market Cap
$2.97M
Enterprise Value
$-5,486,270
P/E Ratio
0.0x
PEG Ratio
0.0x
Price/Sales
N/A
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+1,844.2%
Current Ratio
76.2x
Debt/Equity
0.0x
ROE
+14.9%
ROA
-103.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Hancock Jaffe Laboratories Inc (HJLI) Business Model
About Hancock Jaffe Laboratories Inc
What They Do
N/A
Business Model
N/A
Additional Information
N/A
Company Information
Hancock Jaffe Laboratories Inc (HJLI) Latest News & Analysis
Latest News
Hancock Jaffe To Rebrand As enVVeno Medical
4 years ago
Quick Summary
Hancock Jaffe Laboratories Inc (NASDAQ: HJLI) will rebrand as enVVeno Medical Corporation (ticker: NVNO) on October 1, focusing exclusively on the VenoValve for venous disease treatment.
Why It Matters
The rebranding and strategic focus shift to the VenoValve may signal a more concentrated business approach, potentially impacting investor confidence and future stock performance.
Source: Benzinga
Market Sentiment:
Positive
Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann
4 years ago
Quick Summary
Hancock Jaffe Laboratories CEO Robert Berman will host a webinar on September 27, 2021, at 1:00 PM ET, as part of The Duologue Series by Ladenburg Thalmann.
Why It Matters
The webinar offers insights into Hancock Jaffe's strategy and product developments, which could impact stock performance and investor sentiment in the medical device sector.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Hancock Jaffe will rebrand as enVVeno Medical Corporation (NASDAQ: NVNO) on October 1, 2021, focusing on venous disease and developing a new product by mid-2022. A conference call is scheduled for today.
Why It Matters
The rebranding to enVVeno Medical and focus on venous disease signals a strategic pivot, potentially enhancing market presence and investor interest in innovative medical solutions.
Source: Accesswire
Market Sentiment:
Neutral
Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021
4 years ago
Quick Summary
Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) will host a corporate update conference call with a live video webcast on September 21, 2021, at 4:30 p.m. ET.
Why It Matters
The upcoming conference call may reveal key developments about Hancock Jaffe's products and financial health, influencing investor sentiment and stock performance.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Hancock Jaffe Laboratories (NASDAQ: HJLI) has secured a $20 million investment from Perceptive Advisors through a registered direct offering of 2,540,650 shares at $7.8720 each.
Why It Matters
Hancock Jaffe's $20 million capital raise strengthens its financial position, enabling further development of medical devices, which could enhance growth prospects and investor confidence.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Hancock Jaffe Laboratories is developing bioprosthetics for cardiovascular diseases and received IDE approval in April 2021 to commence a pivotal trial of its VenoValve in the U.S.
Why It Matters
Hancock Jaffe's IDE approval for VenoValve indicates progress in innovative treatments, potentially increasing market value and attracting investor interest in biotech advancements.
Source: Seeking Alpha
Market Sentiment:
Positive
Frequently Asked Questions About HJLI Stock
What is Hancock Jaffe Laboratories Inc's (HJLI) stock forecast for 2026?
Analyst forecasts for Hancock Jaffe Laboratories Inc (HJLI) are not currently available. The stock is trading at $0.34.
Is HJLI stock a good investment in 2026?
Analyst ratings for HJLI are not currently available. The stock is currently trading at $0.34. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HJLI stock?
Price predictions from Wall Street analysts for HJLI are not currently available. The stock is trading at $0.34.
What is Hancock Jaffe Laboratories Inc's business model?
N/A
What is the highest forecasted price for HJLI Hancock Jaffe Laboratories Inc?
Price targets from Wall Street analysts for HJLI are not currently available. The stock is trading at $0.34.
What is the lowest forecasted price for HJLI Hancock Jaffe Laboratories Inc?
Price targets from Wall Street analysts for HJLI are not currently available. The stock is trading at $0.34.
What is the overall HJLI consensus from analysts for Hancock Jaffe Laboratories Inc?
Analyst ratings for HJLI are not currently available. The stock is trading at $0.34.
How accurate are HJLI stock price projections?
Stock price projections, including those for Hancock Jaffe Laboratories Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 19, 2026 7:38 AM UTC